authors
- Roy, D
- Maertens, J
- Walker, I
- Foley, Ronan
- Lewalle, P
- Selleslag, D
- Velthuis, J
- Gerez, L
- Reitsma, K
- Wagena, E
- Roy, J
- Lachance, S
- Mielke, S
Immunotherapy with donor lymphocytes depleted of anti-host reactive cells results in safe and efficacious haploidentical HSCT: interim results from a phase II trial in patients with hematologic malignancies
Conferences
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- April 2014
has subject area
- 1103 Clinical Sciences (FoR)
- Immunology (Science Metrix)
published in
- Cytotherapy Journal